With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
As more countries rise out of poverty, CGD’s work in this area focuses on the inequities and emerging problems that jeopardize global health progress.
As more countries rise out of poverty, CGD is focusing on the inequities and emerging problems that jeopardize global health progress: How should governments allocate scarce health budgets rationally and equitably? How can the world advance global health security and fight infectious diseases? What can be done to address treatment inequalities between developed and developing countries? What are the benefits of, mechanisms for, and threats to, greater family planning provision? CGD research helps policymakers build sustainable health systems, respond to shifting realities, and deliver value for money.
The launch of the Cameroon Cataract Development Impact Loan—a Development Impact Bond (DIB) to provide cataract surgery services via a social enterprise model—marks a key moment in the history of results-based financing. The cataract bond is the first DIB to have a development finance institution (DFI) as an investor, and among the first pay-for-performance projects in eye care to assess the quantity, quality, equity, and financial sustainability of the services provided. Please join us for a discussion on the development of the bond and the experiences of the cataract bond partner organizations, as well as lessons learned from other health-related impact bonds and what it all suggests for the future of pay-for-success for health.
DFID's new chief economist Rachel Glennerster on her goals for the organization, how to help girls stay in school, and why even low price barriers can pose big problems for takeup of health interventions.
Here at CGD, we’re always working on new ideas to stay on top of the rapidly changing global development landscape. Whether it’s examining new technologies with the potential to alleviate poverty, presenting innovative ways to finance global health, assessing changing leadership at international institutions, or working to maximize results in resource-constrained environments, CGD’s experts are at the forefront of practical policy solutions to reduce global poverty and inequality. Get an in-depth look below at their thoughts on the 2018 global development landscape.
What's going to happen in the world of development in 2018? Will we finally understand how to deal equitably with refugees and migrants? Or how technological progress can work for developing countries? Or what the impact of year two of the Trump Administration will be? Today’s podcast, our final episode of 2017, raises these questions and many more as a multitude of CGD scholars share their insights and hopes for the year ahead.
The Sustainable Development Goals are an ambitious set of targets for global development progress by 2030 that were agreed by the United Nations in 2015. A review of the literature on meeting "zero targets" suggests very high costs compared to available resources, but also that in many cases there remains a considerable gap between financing known technical solutions and achieving the outcomes called for in the SDGs. In some cases, we (even) lack the technical solutions required to achieve the zero targets, suggesting the need for research and development of new approaches.
This post previews preliminary answers to one initial question: what can we say about the size and nature of health commodity markets in low- and middle-income countries? We share early insights; list the data sources we used, while also signalling others we hope to draw on going forward; and highlight our assumptions and caveats.
Please join CGD for a conversation with four former directors of USAID’s Office of Population and Reproductive Health. These four leaders served between 1986 and 2013—and their tenures have spanned US administrations from Ronald Reagan to Barack Obama. Since the Office’s inception in 1969, the US government has played a substantial role in supporting expanded access to voluntary family planning around the world through technical assistance, diplomatic and policy engagement, and financial support. But differences in policy across administrations have meant that US leadership in international family planning has often faced periods of uncertainty. CGD is convening this panel to revisit historic experiences and to shed light on lessons learned that may be used to inform stakeholders in the current landscape.
What can we say about the relative size and composition of health commodity markets across different countries? We took a stab at piecing together publicly available data sources to find an initial answer for low- and middle-income countries as part of the background work to inform the CGD Working Group on the Future of Global Health Procurement.